P Mezquita

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Methimazole-Induced Aplastic Anemia in Third Exposure: Successful Treatment with Recombinant Human Granulocyte Colony-Stimulating Factor

P Mezquita, Victor M. Luna, Manuel Muñoz‐Torres et al. · Thyroid · 1998 · 29 citations

NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon

P Mezquita, Breanna Beard, HP Kiem · Gene Therapy · 2008 · 20 citations

Signal Transduction, Cell Division, Cell Interaction +8

Factors associated with microalbuminuria in Type 1 diabetes mellitus: a cross-sectional study

Maria Mar Campos-Pastor, F. Escobar‐Jiménez, P Mezquita et al. · Diabetes Research and Clinical Practice · 2000 · 18 citations

Type 1, Urology, Diabetes Epidemiology +7